Voyager Therapeutics (VYGR) Return on Sales (2015 - 2026)

Voyager Therapeutics (VYGR) has 12 years of Return on Sales data on file, last reported at 0.11% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales fell 6.0% year-over-year to 0.11%; the trailing twelve-month figure through Mar 2026 stood at 0.03% (down 2.0% YoY), and the FY2025 full-year result was 0.03%, down 2.0% from the prior year.
• Return on Sales eased to 0.11% in Q1 2026, from 0.02% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.15% in Q4 2022 to a low of 0.32% in Q1 2022.
• A 5-year average of 0.05% and a median of 0.02% in 2025 frame the typical range for Return on Sales.
• Peak annual rise in Return on Sales reached 57 bps in 2022, while the deepest fall reached 19 bps in 2022.
• Tracing VYGR's Return on Sales over 5 years: stood at 0.15% in 2022, then tumbled by 96 bps to 0.01% in 2023, then plunged by 943 bps to 0.05% in 2024, then surged by 67 bps to 0.02% in 2025, then slumped by 504 bps to 0.11% in 2026.
• Business Quant data shows VYGR's Return on Sales at 0.11% in Q1 2026, 0.02% in Q4 2025, and 0.02% in Q3 2025.